These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12069817)

  • 1. Phosphoinositide 3-kinases in lysophosphatidic acid signaling: regulation and cross-talk with the Ras/mitogen-activated protein kinase pathway.
    Yart A; Chap H; Raynal P
    Biochim Biophys Acta; 2002 May; 1582(1-3):107-11. PubMed ID: 12069817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid.
    Yart A; Roche S; Wetzker R; Laffargue M; Tonks N; Mayeux P; Chap H; Raynal P
    J Biol Chem; 2002 Jun; 277(24):21167-78. PubMed ID: 11916960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase.
    Fang X; Yu S; LaPushin R; Lu Y; Furui T; Penn LZ; Stokoe D; Erickson JR; Bast RC; Mills GB
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):135-43. PubMed ID: 11062066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epidermal growth factor receptor/Gab1 signaling pathway is required for activation of phosphoinositide 3-kinase by lysophosphatidic acid.
    Laffargue M; Raynal P; Yart A; Peres C; Wetzker R; Roche S; Payrastre B; Chap H
    J Biol Chem; 1999 Nov; 274(46):32835-41. PubMed ID: 10551845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
    Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
    J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance.
    Aksamitiene E; Kiyatkin A; Kholodenko BN
    Biochem Soc Trans; 2012 Feb; 40(1):139-46. PubMed ID: 22260680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases.
    Grey A; Banovic T; Naot D; Hill B; Callon K; Reid I; Cornish J
    Endocrinology; 2001 Mar; 142(3):1098-106. PubMed ID: 11181524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic action of LPA in prostate.
    Daaka Y
    Biochim Biophys Acta; 2002 May; 1582(1-3):265-9. PubMed ID: 12069837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lysophosphatidic acid signals through mitogen-activated protein kinase-extracellular signal regulated kinase in ovarian theca cells expressing the LPA1/edg2-receptor: involvement of a nonclassical pathway?
    Budnik LT; Brunswig-Spickenheier B; Mukhopadhyay AK
    Mol Endocrinol; 2003 Aug; 17(8):1593-606. PubMed ID: 12730329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: role of PI 3-kinase and ERK.
    Dixon RJ; Brunskill NJ
    Kidney Int; 1999 Dec; 56(6):2064-75. PubMed ID: 10594782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
    Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
    Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific.
    Baudhuin LM; Cristina KL; Lu J; Xu Y
    Mol Pharmacol; 2002 Sep; 62(3):660-71. PubMed ID: 12181443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways.
    Campbell M; Allen WE; Sawyer C; Vanhaesebroeck B; Trimble ER
    Circ Res; 2004 Aug; 95(4):380-8. PubMed ID: 15242975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell receptor-mediated Syk-independent activation of phosphatidylinositol 3-kinase, Ras, and mitogen-activated protein kinase pathways.
    Yokozeki T; Adler K; Lankar D; Bonnerot C
    J Immunol; 2003 Aug; 171(3):1328-35. PubMed ID: 12874222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ras-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists.
    Kranenburg O; Moolenaar WH
    Oncogene; 2001 Mar; 20(13):1540-6. PubMed ID: 11313900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic Acid Stimulates Ovarian Cancer Cell Migration via a Ras-MEK Kinase 1 Pathway.
    Bian D; Su S; Mahanivong C; Cheng RK; Han Q; Pan ZK; Sun P; Huang S
    Cancer Res; 2004 Jun; 64(12):4209-17. PubMed ID: 15205333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins.
    Reiser CO; Lanz T; Hofmann F; Hofer G; Rupprecht HD; Goppelt-Struebe M
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1107-14. PubMed ID: 9494074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
    Badache A; Hynes NE
    Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.